ondansetron has been researched along with dolasetron in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (22.22) | 18.2507 |
| 2000's | 34 (62.96) | 29.6817 |
| 2010's | 7 (12.96) | 24.3611 |
| 2020's | 1 (1.85) | 2.80 |
| Authors | Studies |
|---|---|
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Jia, L; Sun, H | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Moser, PC | 1 |
| Gandara, DR; Hesketh, PJ | 1 |
| Alon, E; Biro, P | 1 |
| Anthony, L; Benedict, C; Gralla, R; Grote, T; Hahne, W; Hainsworth, J; Hesketh, P; Khojasteh, A; Kris, M; Navari, R; Tapazoglou, E | 1 |
| David, M; Dow, J; Sanwald, P | 1 |
| Arbogast, R; Benedict, CR; Hahne, W; Martin, L; Morrill, B; Patton, L | 1 |
| Chemaissani, A; Cognetti, F; Conte, PF; Cortes-Funes, H; Del Favero, A; Diaz-Rubio, E; Dressler, H; Duclos, B; Fauser, AA | 1 |
| Kobayashi, S; Kumai, T; Nakura, H; Tanaka, M; Tateishi, T; Watanabe, M | 1 |
| Chin, C; Dempsey, E; Guevin, RM; Hainsworth, J; Hoskins, P; Krook, JE; Lofters, WS; Moquin, JP; Navari, R; Palmer, M; Pater, JL; Verma, S; Walde, D; Wilson, K; Zee, B | 2 |
| Brown, R; Clergue, F; Feiss, P; Hahne, W; Korttila, K; Leeser, J; Nave, S; Olthoff, D; Payeur-Michel, C; Wessel, P | 1 |
| Fisher, DM | 1 |
| Klein, KW; Sa Rego, M; Stewart, DG; Watcha, MF; White, PF; Zarate, E | 1 |
| Benedict, CR; Brown, AM; Kuryshev, YA; Rampe, D; Wang, L | 1 |
| Walker, JB | 1 |
| Keefe, DL | 1 |
| Markman, M | 1 |
| Fluder, E; Hotaling, AJ; Lurie, J; Pappas, AL; Park, A; Sukhani, R | 1 |
| Chen, X; Kariger, R; Ma, H; Naruse, R; Sloninsky, A; Tang, J; Webb, T; Wender, RH; White, PF; Zaentz, A | 1 |
| Miller, DR | 1 |
| Banks, SL; Gurrin, LC; Orlikowski, CE; Paech, MJ; Pavy, TJ; Rucklidge, MW | 1 |
| Alexis, R; Jantzen, EC; Olutoye, O; Rajchert, D; Schreiner, MS; Watcha, MF | 1 |
| Koeller, JM; Navari, RM | 1 |
| Tan, M | 1 |
| Karamanlioglu, B; Memis, D; Süt, N; Turan, A | 1 |
| Grunberg, SM; Koeller, JM | 1 |
| Browning, BA; Fort, CA; Kemp, KD; Shimata, MF; Strube, MD | 1 |
| Davis, J; McLeskey, CH; Meyer, TA; Rajab, MH; Roberson, CR | 1 |
| Rubenstein, EB | 1 |
| Olver, IN | 1 |
| Dimitriou, VK; Dragoumanis, CK; Iatrou, CA; Simopoulos, CE; Vogiatzaki, TD; Vretzakis, GI | 1 |
| White, PF | 1 |
| Cartwright, J; Frangoul, H; Ho, RH; Jones, E; Koyama, T; Kuttesch, J; Shankar, S; Whitlock, JA | 1 |
| Board, R; Board, T | 1 |
| Badr, AE; Calimaran, AM; Mychaskiw, G | 1 |
| Awab, A; Chaudhary, L; Hamadani, M; Tfayli, A | 1 |
| Birmingham, SD; Boyle, PK; Dacanay, RG; Green, R; Lujan, E; Mecklenburg, BW | 1 |
| Arnold, D; Grothey, A; Hinke, A; Jordan, K; Schmoll, HJ; Voigt, W; Wolf, HH | 1 |
| McNulty, R | 1 |
| Wilkes, G | 1 |
| Awan, FT; Chaudhary, L; Hamadani, M; Khan, JK; Kojouri, K; Ozer, H; Tfayli, A | 1 |
| Trepanier, L | 1 |
| Eisenach, JC; Ewan, EE; Hayashida, K; Nakajima, K; Obata, H; Peters, CM; Xu, Q; Yaksh, TL | 1 |
| Ballinari, G; Barbour, SY; Cox, D; Morrow, GR; Schwartzberg, L; Thorn, MD | 1 |
| Obal, D; Sessler, DI; Yang, D | 1 |
| Antony, J; Hemmelgarn, B; Hui, W; Hutton, B; Moher, D; Soobiah, C; Straus, SE; Struchkov, V; Tricco, AC | 1 |
| Benson, C; Brown, R; Couderc, JP; Darpo, B; Dota, C; Ferber, G; Ferry, J; Jarugula, V; Keirns, J; Ortemann-Renon, C; Pham, T; Riley, S; Sarapa, N; Ticktin, M; Zareba, W | 1 |
13 review(s) available for ondansetron and dolasetron
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Prevention and treatment of postoperative nausea and vomiting with 5-HT3-receptor blockers].
Topics: Antiemetics; Clinical Trials as Topic; Dose-Response Relationship, Drug; Granisetron; Humans; Indoles; Infusions, Intravenous; Nausea; Ondansetron; Postoperative Complications; Quinolizines; Serotonin Antagonists; Tropisetron; Vomiting | 1996 |
The cardiotoxic potential of the 5-HT(3) receptor antagonist antiemetics: is there cause for concern?
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Electrocardiography; Granisetron; Heart Failure; Humans; Indoles; Middle Aged; Nausea; Neoplasms; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting | 2002 |
Progress in preventing chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Dexamethasone; Granisetron; Humans; Indoles; Nausea; Neurotransmitter Agents; Ondansetron; Quinolizines; Vomiting | 2002 |
Electrocardiographic and cardiovascular effects of the 5-hydroxytryptamine3 receptor antagonists.
Topics: Antiemetics; Cardiovascular System; Clinical Trials as Topic; Dose-Response Relationship, Drug; Electrocardiography; Granisetron; Humans; Indoles; Ondansetron; Quinolizines; Serotonin Antagonists; Surgical Procedures, Operative | 2003 |
Granisetron: new insights into its use for the treatment of chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Granisetron; Humans; Indoles; Nausea; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting | 2003 |
Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis.
Topics: Antiemetics; Antineoplastic Agents; Humans; Indoles; Isoquinolines; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Randomized Controlled Trials as Topic; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2003 |
Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Topics: Acute Disease; Adult; Aged; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Cytochrome P-450 CYP2D6; Dexamethasone; Female; Half-Life; Humans; Indoles; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Palonosetron; Protein Binding; Quinolizines; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Vomiting | 2004 |
Update on anti-emetics for chemotherapy-induced emesis.
Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Australia; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Granisetron; Humans; Indoles; Isoquinolines; Male; Neoplasms; Ondansetron; Palonosetron; Patient Satisfaction; Prognosis; Quality of Life; Quinolizines; Quinuclidines; Treatment Outcome; Tropisetron; Vomiting | 2005 |
The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting.
Topics: Adult; Algorithms; Antiemetics; Child; Dexamethasone; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Evidence-Based Medicine; Granisetron; Humans; Indoles; Isoquinolines; Nurse's Role; Nursing Assessment; Ondansetron; Operating Room Nursing; Palonosetron; Patient Selection; Postoperative Nausea and Vomiting; Practice Guidelines as Topic; Quinolizines; Quinuclidines; Risk Assessment; Risk Factors; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists | 2006 |
A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.
Topics: Antiemetics; Antineoplastic Agents; Granisetron; Humans; Indoles; Ondansetron; Quinolizines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Tropisetron; Vomiting | 2007 |
Acute vomiting in cats: rational treatment selection.
Topics: Acute Disease; Animals; Antiemetics; Cat Diseases; Cats; Chlorpromazine; Diarrhea; Famotidine; Indoles; Metoclopramide; Nausea; Ondansetron; Prochlorperazine; Quinolizines; Quinuclidines; Ranitidine; Sucralfate; Vomiting; Weight Loss | 2010 |
Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review.
Topics: Antiemetics; Antineoplastic Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Electrocardiography; Humans; Indoles; Isoquinolines; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists | 2015 |
18 trial(s) available for ondansetron and dolasetron
| Article | Year |
|---|---|
Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis P
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Double-Blind Method; Female; Humans; Indoles; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Quinolizines; Remission Induction; Serotonin Antagonists; United States; Vomiting | 1996 |
Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers.
Topics: Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Electrocardiography; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Ondansetron; Quinolizines; Serotonin Antagonists; Time Factors | 1996 |
Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study Group.
Topics: Adult; Aged; Analysis of Variance; Antiemetics; Antineoplastic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Indoles; Logistic Models; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Patient Satisfaction; Quinolizines; Risk Factors; Therapeutic Equivalency; Vomiting | 1996 |
The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
Topics: Antiemetics; Female; Humans; Indoles; Nausea; Ondansetron; Quinolizines; Serotonin Antagonists; Vomiting | 1997 |
Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.
Topics: Administration, Oral; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Premedication; Quality of Life; Quinolizines; Vomiting | 1997 |
Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study.
Topics: Adult; Aged; Antiemetics; Double-Blind Method; Female; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Nausea; Ondansetron; Postoperative Complications; Quinolizines; Serotonin Antagonists; Vomiting | 1997 |
A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis.
Topics: Ambulatory Surgical Procedures; Antiemetics; Costs and Cost Analysis; Double-Blind Method; Humans; Indoles; Ondansetron; Postoperative Nausea and Vomiting; Quinolizines | 2000 |
Ondansetron and dolasetron provide equivalent postoperative vomiting control after ambulatory tonsillectomy in dexamethasone-pretreated children.
Topics: Ambulatory Surgical Procedures; Antiemetics; Child; Child, Preschool; Dexamethasone; Double-Blind Method; Female; Humans; Indoles; Infant; Male; Ondansetron; Postoperative Nausea and Vomiting; Quinolizines; Tonsillectomy | 2002 |
Antiemetic prophylaxis for office-based surgery: are the 5-HT3 receptor antagonists beneficial?
Topics: Aged; Ambulatory Surgical Procedures; Antiemetics; Female; Humans; Indoles; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Preanesthetic Medication; Quinolizines; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists | 2003 |
The efficacy and cost-effectiveness of prophylactic 5-hydroxytryptamine3 receptor antagonists: tropisetron, ondansetron and dolasetron.
Topics: Antiemetics; Cost-Benefit Analysis; Double-Blind Method; Female; Humans; Indoles; Middle Aged; Ondansetron; Patient Satisfaction; Postoperative Nausea and Vomiting; Quinolizines; Serotonin Antagonists; Tropisetron | 2003 |
A comparison of the costs and efficacy of ondansetron and dolasetron in the prophylaxis of postoperative vomiting in pediatric patients undergoing ambulatory surgery.
Topics: Ambulatory Surgical Procedures; Anesthesia, General; Child; Child, Preschool; Double-Blind Method; Drug Costs; Female; Hospital Costs; Humans; Indoles; Male; Ondansetron; Postoperative Nausea and Vomiting; Quinolizines | 2003 |
Comparison of oral dolasetron and ondansetron in the prophylaxis of postoperative nausea and vomiting in children.
Topics: Acetaminophen; Administration, Oral; Analgesics, Non-Narcotic; Anesthesia Recovery Period; Antiemetics; Chi-Square Distribution; Child; Double-Blind Method; Female; Humans; Indoles; Male; Ondansetron; Pain Measurement; Postoperative Nausea and Vomiting; Quinolizines; Surgical Procedures, Operative; Time Factors; Treatment Outcome | 2003 |
Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures.
Topics: Antiemetics; Cost Savings; Double-Blind Method; Drug Costs; Female; Gynecologic Surgical Procedures; Humans; Incidence; Indoles; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Quinolizines; Severity of Illness Index; Time Factors; Treatment Outcome | 2004 |
Dolasetron versus ondansetron for the treatment of postoperative nausea and vomiting.
Topics: Adolescent; Adult; Aged; Ambulatory Surgical Procedures; Anesthesia, General; Antiemetics; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Quinolizines; Sample Size | 2005 |
Prophylactic intravenous ondansetron and dolasetron in intrathecal morphine-induced pruritus: a randomized, double-blinded, placebo-controlled study.
Topics: Adult; Aged; Analgesics, Opioid; Double-Blind Method; Female; Humans; Indoles; Injections, Spinal; Male; Middle Aged; Morphine; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Pruritus; Quinolizines | 2005 |
Dolasetron versus ondansetron as single-agent prophylaxis for patients at increased risk for postoperative nausea and vomiting: a prospective, double-blind, randomized trial.
Topics: Adolescent; Adult; Ambulatory Surgical Procedures; Anesthesia, General; Antiemetics; Chemoprevention; Double-Blind Method; Female; Humans; Indoles; Male; Ondansetron; Patient Satisfaction; Postoperative Nausea and Vomiting; Quinolizines; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2006 |
Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV).
Topics: Antiemetics; Antineoplastic Agents; Double-Blind Method; Female; Granisetron; Humans; Indoles; Isoquinolines; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Serotonin Antagonists; Treatment Outcome; Vomiting | 2014 |
Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From the IQ-CSRC Study.
Topics: Arrhythmias, Cardiac; Biomarkers; Cetirizine; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Indoles; Ion Channels; Long QT Syndrome; Male; Moxifloxacin; Ondansetron; Phenethylamines; Quinine; Quinolizines; Risk Assessment; Sulfonamides | 2020 |
23 other study(ies) available for ondansetron and dolasetron
| Article | Year |
|---|---|
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
The effect of 5-HT3 receptor antagonists on the discriminative stimulus effects of amphetamine.
Topics: Amphetamine; Animals; Discrimination Learning; Imidazoles; Indoles; Male; Ondansetron; Quinolizines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Tropanes; Tropisetron | 1992 |
Serotonin antagonists: a new class of antiemetic agents.
Topics: Antiemetics; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Granisetron; Humans; Imidazoles; Indazoles; Indoles; Metoclopramide; Ondansetron; Quinolizines; Receptors, Serotonin; Serotonin Antagonists; Tropanes; Tropisetron; Vomiting | 1991 |
Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of dolasetron. Comparison with other indole-containing 5-HT3 antagonists.
Topics: Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Hydroxylation; Indoles; Male; Mass Spectrometry; Microsomes, Liver; Mixed Function Oxygenases; Molecular Structure; Ondansetron; Oxidation-Reduction; Quinolizines; Serotonin Antagonists; Tropisetron | 1996 |
The activity of dihydropyrimidine dehydrogenase from rat liver was not affected by any of five 5-hydroxytryptamine antagonists.
Topics: Animals; Antiemetics; Antimetabolites, Antineoplastic; Biotransformation; Bridged Bicyclo Compounds, Heterocyclic; Cytosol; Dihydrouracil Dehydrogenase (NADP); Fluorouracil; Granisetron; Indoles; Liver; Male; Ondansetron; Oxazines; Oxidoreductases; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Tropisetron | 1996 |
Surrogate outcomes: meaningful not!
Topics: Anesthesia; Antiemetics; Granisetron; Humans; Indoles; Ondansetron; Postoperative Nausea and Vomiting; Quinolizines | 1999 |
Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.
Topics: Antiemetics; Cation Transport Proteins; Cell Line; Cloning, Molecular; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electric Stimulation; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Granisetron; Heart; Humans; Indoles; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Ondansetron; Potassium Channels; Potassium Channels, Voltage-Gated; Quinolizines; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Sodium Channels; Trans-Activators; Transcriptional Regulator ERG; Transfection | 2000 |
Efficacy of single-dose intravenous dolasetron versus ondansetron in the prevention of postoperative nausea and vomiting.
Topics: Adult; Antiemetics; Cholecystectomy, Laparoscopic; Female; Humans; Hysterectomy; Indoles; Injections, Intravenous; Male; Obesity; Ondansetron; Postoperative Nausea and Vomiting; Quinolizines | 2001 |
Arrhythmogenic potential of antiemetics: perspectives on risk-benefits.
Topics: Antiemetics; Arrhythmias, Cardiac; Atrial Fibrillation; Droperidol; Electrocardiography; Humans; Indoles; Ondansetron; Postoperative Nausea and Vomiting; Quinolizines | 2003 |
5HT3-receptor antagonists as antiemetics in cancer.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Granisetron; Humans; Indoles; Isoquinolines; Nausea; Neoplasms; Ondansetron; Palonosetron; Practice Guidelines as Topic; Quinolizines; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Tropisetron; Vomiting | 2005 |
Treatment of postoperative nausea and vomiting with dolasetron versus ondansetron: is there a conflict of interest?
Topics: Antiemetics; Conflict of Interest; Humans; Indoles; Ondansetron; Postoperative Nausea and Vomiting; Quinolizines | 2005 |
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Confusion; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; Female; Granisetron; Humans; Indoles; Infusion Pumps; Infusions, Intravenous; Length of Stay; Lorazepam; Male; Mood Disorders; Ondansetron; Patient Acceptance of Health Care; Quinolizines; Retrospective Studies; Self Administration; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Vomiting | 2007 |
Ethics, marketing, and the medical literature.
Topics: Antiemetics; Conflict of Interest; Drug Industry; Humans; Indoles; Marketing; Ondansetron; Postoperative Nausea and Vomiting; Quinolizines | 2006 |
Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
Topics: Antiemetics; Granisetron; Humans; Indoles; Isoquinolines; Nausea; Ondansetron; Organoplatinum Compounds; Palonosetron; Quinolizines; Quinuclidines; Treatment Outcome; Vomiting | 2006 |
Are all 5-HT3 receptor antagonists the same?
Topics: Humans; Indoles; Isoquinolines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Randomized Controlled Trials as Topic; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Therapeutic Equivalency; Vomiting | 2007 |
Antiemetic agents.
Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipation; Diarrhea; Drug Interactions; Dyspepsia; Fatigue; Fever; Granisetron; Headache; Hiccup; Humans; Indoles; Injections, Intravenous; Isoquinolines; Morpholines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Vomiting | 2007 |
Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Female; Granisetron; Humans; Indoles; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Platinum Compounds; Quinolizines; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2007 |
Lack of analgesic efficacy of spinal ondansetron on thermal and mechanical hypersensitivity following spinal nerve ligation in the rat.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Indoles; Injections, Spinal; Ligation; Ondansetron; Pain; Quinolizines; Rats; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Spinal Nerves | 2010 |
Perioperative doses of ondansetron or dolasetron do not lengthen the QT interval.
Topics: Aged; Aged, 80 and over; Female; Heart Rate; Humans; Indoles; Long QT Syndrome; Male; Middle Aged; Ondansetron; Postoperative Complications; Postoperative Period; Preoperative Care; Quinolizines; Serotonin 5-HT3 Receptor Antagonists; Young Adult | 2014 |